Floatz logo

Immunoglobulin G4, Anti-(Human Programmed Cell Death Protein 1) (Human Monoclonal Regn2810 Heavy Chain), Disulfide With Human Monoclonal Regn2810 .Kappa.-Chain, Dimer

Skin Squamous Cell Carcinoma

Regeneron Pharmaceuticalsmonoclonal_antibodyPhase 3Active
BB
66/ 100
Provisional rating · Methodology v0.2

Rating breakdown

Clinical Evidence
59/ 100
Competitive Position
81/ 100

Competitive context

55 Active assets in the Skin Squamous Cell Carcinoma cohort.

Asset / SponsorPhaseRating
Prednisone
Dana-Farber Cancer Institute
Phase 4BB
Sirolimus
Dana-Farber Cancer Institute
Phase 4BB
Technetium-99
Institut de Cancérologie de Lorraine
Phase 3BB
Everolimus
Dana-Farber Cancer Institute
Phase 4BB
Indocyanine Green
Institut de Cancérologie de Lorraine
Phase 3BB

View all 50 →

Same molecule, other indications

Immunoglobulin G4, Anti-(Human Programmed Cell Death Protein 1) (Human Monoclonal Regn2810 Heavy Chain), Disulfide With Human Monoclonal Regn2810 .Kappa.-Chain, Dimer is also rated in:

lung cancerActive
BB
Indicative · Phase 2/3
65 / 100
View asset →
nonpapillary renal cell carcinomaActive
BB
Indicative · Phase 2
65 / 100
View asset →
plasma cell myelomaActive
B
Indicative · Phase 2
63 / 100
View asset →

Need depth?

Order a full diligence report on this asset.

Order report →

Are you the sponsor?

Submit your data room for a Verified Rating. The public-data rating remains visible alongside.

Contact →